On the public citation graph
Long‐term follow‐up assessment of opioid use outcomes among individuals with comorbid mental disorders and opioid use disorder treated with buprenorphine or methadone in a randomized clinical trial
0 signed · 57 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1001/jamapsychiatry.2018.3537openalex-snapshot
Anxiety, Depression, and Insomnia Among Adults With Opioid Dependence Treated With Extended-Release Naltrexone vs Buprenorphine-Naloxone
inferredcites →https://doi.org/10.1002/sim.5510openalex-snapshot
Statistical models for longitudinal zero‐inflated count data with applications to the substance abuse field
inferredcites →https://doi.org/10.1016/j.drugalcdep.2012.06.020openalex-snapshot
Prevalence of mood and substance use disorders among patients seeking primary care office-based buprenorphine/naloxone treatment
inferredcites →https://doi.org/10.1016/j.drugalcdep.2012.08.002openalex-snapshot
Buprenorphine/Naloxone and methadone effects on laboratory indices of liver health: A randomized trial
inferredcites →https://doi.org/10.1016/j.drugalcdep.2018.12.030openalex-snapshot
Co-occurring substance use and mental disorders among adults with opioid use disorder
inferredcites →https://doi.org/10.1016/j.drugalcdep.2020.108122openalex-snapshot
Depression history as a predictor of outcomes during buprenorphine-naloxone treatment of prescription opioid use disorder
inferredcites →https://doi.org/10.1016/s0022-3565(25)10630-7openalex-snapshot
Serotonin and norepinephrine uptake inhibiting activity of centrally acting analgesics: structural determinants and role in antinociception.
inferredcites →https://doi.org/10.1017/s0033291720000525openalex-snapshot
Buprenorphine: prospective novel therapy for depression and PTSD
inferredcites →https://doi.org/10.1038/s41380-018-0284-1openalex-snapshot
Opioid system modulation with buprenorphine/samidorphan combination for major depressive disorder: two randomized controlled studies
inferredcites →https://doi.org/10.1080/10550880802122646openalex-snapshot
Psychotherapeutic Benefits of Opioid Agonist Therapy
inferredcites →https://doi.org/10.1097/00002508-200207001-00003openalex-snapshot
Assessment and Treatment of Comorbid Psychiatric Disorders in Opioid-Dependent Patients
inferredcites →https://doi.org/10.1111/ajad.12644openalex-snapshot
The impact of mental health comorbidities on adherence to buprenorphine: A claims based analysis
inferredcites →https://doi.org/10.1111/j.1521-0391.2012.00271.xopenalex-snapshot
Posttraumatic Stress Disorder and One‐Year Outcome in Methadone Maintenance Treatment
inferredcites →https://doi.org/10.1111/j.1524-4733.2006.00139.xopenalex-snapshot
A Checklist for Medication Compliance and Persistence Studies Using Retrospective Databases
inferredcites →https://doi.org/10.1126/scitranslmed.3005656openalex-snapshot
Amygdala-Dependent Fear Is Regulated by Oprl1 in Mice and Humans with PTSD
inferredcites →https://doi.org/10.1176/appi.ajp.160.5.890openalex-snapshot
The Role of Psychiatric Disorders in Predicting Drug Dependence Treatment Outcomes
inferredcites →https://doi.org/10.1186/1744-859x-10-17openalex-snapshot
Do methadone and buprenorphine have the same impact on psychopathological symptoms of heroin addicts?
inferredcites →https://doi.org/10.1191/1471082x05st084oaopenalex-snapshot
Random effect models for repeated measures of zero-inflated count data
inferredcites →https://doi.org/10.1523/jneurosci.2444-15.2015openalex-snapshot
Kappa Opioid Receptor-Induced Aversion Requires p38 MAPK Activation in VTA Dopamine Neurons
inferredcites →https://doi.org/10.15288/jsa.2006.67.228openalex-snapshot
Opioid substitution treatment reduces substance use equivalently in patients with and without posttraumatic stress disorder.
inferredcites →https://doi.org/10.2105/ajph.2014.301966openalex-snapshot
Determinants of Increased Opioid-Related Mortality in the United States and Canada, 1990–2013: A Systematic Review
inferredcites →https://doi.org/10.2147/nbhiv.s12371openalex-snapshot
Rates of mood and anxiety disorders and contributors to continued heroin use in methadone maintenance patients: A comparison by HIV status
inferredcites →https://doi.org/10.2147/ndt.s129480openalex-snapshot
The impact of comorbid psychiatric disorders on methadone maintenance treatment in opioid use disorder: a prospective cohort study
inferredcites →https://doi.org/10.3109/00952990.2013.842241openalex-snapshot
Baseline characteristics and treatment outcomes in prescription opioid dependent patients with and without co-occurring psychiatric disorder
inferredcites →https://doi.org/10.3109/10550490903205652openalex-snapshot
Psychiatric Comorbidity Reduces Quality of Life in Chronic Methadone Maintained Patients
inferredcites →https://doi.org/10.3390/ijerph6112822openalex-snapshot
Impact of Co-Occurring Psychiatric Disorders on Retention in a Methadone Maintenance Program: An 18-Month Follow-Up Study
inferredcites →https://doi.org/10.3390/ijms19082410openalex-snapshot
The Efficacy of Buprenorphine in Major Depression, Treatment-Resistant Depression and Suicidal Behavior: A Systematic Review
inferredcites →https://doi.org/10.4088/jcp.15m09893openalex-snapshot
Observational Evidence for Buprenorphine’s Impact on Posttraumatic Stress Symptoms in Veterans With Chronic Pain and Opioid Use Disorder
inferredcites →https://doi.org/10.4088/jcp.v67n0211openalex-snapshot
Lifetime Comorbidity of DSM-IV Mood and Anxiety Disorders and Specific Drug Use Disorders
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.2139/ssrn.4780710openalex-extracted
Improving Engagement in Residential Treatment for Sud: Integrated-Care Qi Project
inferred← citeshttps://doi.org/10.1002/14651858.cd011117.pub3openalex-snapshot
Opioid agonist treatment for people who are dependent on pharmaceutical opioids
inferred← citeshttps://doi.org/10.1007/s40429-026-00795-3openalex-snapshot
Mental health Disorders in Opioid Use Disorders – Focus on Depression and Anxiety
inferred← citeshttps://doi.org/10.1016/j.dhjo.2026.102130openalex-snapshot
“Cognitive impairments are the worst”: Staff perspectives on challenges in buprenorphine care for people with cognitive and mental health disabilities who inject drugs
inferred← citeshttps://doi.org/10.1016/j.drugalcdep.2025.112768openalex-snapshot
The association between mental disorders and treatment retention among people with opioid use disorder receiving opioid agonist treatment: A systematic review and meta-analysis
inferred← citeshttps://doi.org/10.1016/j.josat.2024.209289openalex-snapshot
Timing of treatment for opioid use disorder among birthing people
inferred← citeshttps://doi.org/10.1016/j.nurpra.2024.105174openalex-snapshot
Improving Engagement in Residential Treatment for Substance Use Disorders: An Integrated Care Quality Improvement Project for Individuals With Mental Health and Substance Use Disorders
inferred← citeshttps://doi.org/10.1016/j.peptides.2023.171095openalex-snapshot
Endogenous opiates and behavior: 2022
inferred← citeshttps://doi.org/10.1038/s41598-024-80767-7openalex-snapshot
Male and female behavioral variability and morphine response in C57BL/6J, DBA/2J, and their BXD progeny following chronic stress exposure
inferred← citeshttps://doi.org/10.1080/10550887.2024.2354566openalex-snapshot
Long-acting injectable buprenorphine in the real world: case report on dual disorders
inferred← citeshttps://doi.org/10.1080/15332640.2025.2545975openalex-snapshot
The characteristics of drug users in rehabilitation centers in the West Bank, Palestine: A retrospective descriptive study
inferred← citeshttps://doi.org/10.1080/16066359.2025.2605955openalex-snapshot
Preexisting morbidity and 2-year treatment retention in opioid agonist treatment. A population-based data-linkage study in the Czech Republic
inferred← citeshttps://doi.org/10.1097/adm.0000000000001420openalex-snapshot
Collaborating With Jails to Provide Community-based Medication for Opioid Use Disorder: Qualitative Perspectives From MOUD Treatment Providers
inferred← citeshttps://doi.org/10.1097/nmd.0000000000001883openalex-snapshot
Psychiatric Comorbidity in Research on Medications for Opioid Use Disorder
inferred← citeshttps://doi.org/10.1101/2024.02.23.581795openalex-snapshot
Male and female variability in response to chronic stress and morphine in C57BL/6J, DBA/2J, and their BXD progeny
inferred← citeshttps://doi.org/10.1101/2025.11.10.687622openalex-snapshot
A Challenge To The Assumption That Short- versus Long-Access Groups of Opioid Users Represent Distinct Phenotypes
inferred← citeshttps://doi.org/10.1111/add.16115openalex-snapshot
Long‐term recovery from opioid use disorder: recovery subgroups, transition states and their association with substance use, treatment and quality of life
inferred← citeshttps://doi.org/10.1176/appi.ajp.21090964openalex-snapshot
Flexible Buprenorphine/Naloxone Model of Care for Reducing Opioid Use in Individuals With Prescription-Type Opioid Use Disorder: An Open-Label, Pragmatic, Noninferiority Randomized Controlled Trial
inferred← citeshttps://doi.org/10.1177/1357633x231190945openalex-snapshot
Telemedicine-delivered treatment for substance use disorder: A scoping review
inferred← citeshttps://doi.org/10.1186/s12884-026-09256-1openalex-snapshot
The comparative effects of prenatal exposure to methadone versus buprenorphine for opioid use disorder on neonatal outcomes: a systematic review and meta-analysis
inferred← citeshttps://doi.org/10.1186/s13011-026-00752-3openalex-snapshot
Unemployment & opioid use disorder – socio-medical assessment results by the Medical Service of the German Federal Employment Agency
inferred← citeshttps://doi.org/10.1186/s13722-024-00467-5openalex-snapshot
Exploring dual diagnosis in opioid agonist treatment patients: a registry-linkage study in Czechia and Norway
inferred← citeshttps://doi.org/10.1371/journal.pone.0314296openalex-snapshot
Hospital and physician-based mental healthcare during 12 months of opioid agonist treatment for opioid use disorder: Exploring costs and factors associated with acute care
inferred← citeshttps://doi.org/10.2147/sar.s475807openalex-snapshot
Community-Based Medications First for Opioid Use Disorder - Care Utilization and Mortality Outcomes
inferred← citeshttps://doi.org/10.31219/osf.io/szh96openalex-snapshot
Exploring dual diagnosis in opioid agonist treatment patients: A registry-linkage study in Czechia and Norway
inferred← citeshttps://doi.org/10.3389/fphar.2021.718811openalex-snapshot
Transition From Full Mu Opioid Agonists to Buprenorphine in Opioid Dependent Patients—A Critical Review
inferred← citeshttps://doi.org/10.6084/m9.figshare.25815093openalex-snapshot
Additional file 1 of Exploring dual diagnosis in opioid agonist treatment patients: a registry-linkage study in Czechia and Norway
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.